Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine

被引:35
作者
Stringer, JSA
Sinkala, M
Chapman, V
Acosta, EP
Aldrovandi, GM
Mudenda, V
Stout, JP
Goldenberg, RL
Kumwenda, R
Vermund, SH
机构
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL USA
[3] Univ Zambia, Sch Med, Lusaka, Zambia
[4] Ctr Infect Dis Res Zambia, Lusaka, Zambia
[5] Zambian Minist Hlth, Lusaka Urban Dist Hlth Management Board, Lusaka, Zambia
[6] Univ Teaching Hosp, Lusaka, Zambia
[7] United Nat Dev Program, Lusaka, Zambia
关键词
HIV; perinatal; nevirapine; timing; Zambia;
D O I
10.1097/00002030-200307250-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Context: Single-dose intrapartum and neonatal nevirapine (NVP) reduces perinatal HIV transmission and is in increasingly common use throughout the developing world. Objective: We studied risk factors for perinatal transmission in the setting of NVP. Design and setting: A prospective cohort study at two public obstetrical clinics in Lusaka, Zambia. Patients and methods: In a volunteer sample of HIV-infected pregnant women and their newborns, the women received a 200 mg oral dose of NVP at the onset of labor; their infants received 2 mg/kg of NVP syrup within 24 h of birth. The main outcome measure was the infant HIV infection status at 6 weeks of life, determined by DNA polymerase chain reaction. Results: Only 31 of 278 (11.2%) infants were infected at 6 weeks. In logistic regression, viral load exceeding the median [adjusted odds ratio (AOR), 3.1; 95% confidence interval (CI), 1.1-8.7] and 1 h or less elapsing between NVP ingestion and delivery (AOR, 5.0; 95% CI, 1.8-14) were associated with transmission. Women delivering within 1 h of NVP ingestion had a lower mean drug concentration (351 versus 942 ng/ml; P < 0.001) and were more likely to have a 'sub-therapeutic' NVP level of less than 100 ng/ml (56 versus 20%; P < 0.001) than those who delivered more than 1 h post-ingestion. However, concentrations < 100 ng/ml were not more likely to be associated with transmission than concentrations greater than or equal to100 ng/ml (12.9 versus 11.7%; P = 0.8). We did not identify a threshold concentration below which risk of transmission increased. Conclusions: We confirmed low perinatal transmission rates with single-dose NVP. At least 1 h of pre-delivery NVP prophylaxis was a critical threshold for efficacy. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:1659 / 1665
页数:7
相关论文
共 21 条
[1]  
[Anonymous], 2002, REPORT GLOBAL HIVAID
[2]   Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field [J].
Beck, IA ;
Drennan, KD ;
Melvin, AJ ;
Mohan, KM ;
Herz, AM ;
Alarcón, J ;
Piscoya, J ;
Velázquez, C ;
Frenkel, LM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) :29-33
[3]  
BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718
[4]  
BUYSE D, 2002, 14 INT AIDS C BARC S
[5]   Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study [J].
Coutsoudis, A ;
Pillay, K ;
Spooner, E ;
Kuhn, L ;
Coovadia, HM .
LANCET, 1999, 354 (9177) :471-476
[6]   High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction [J].
Dailly, E ;
Thomas, L ;
Kergueris, MF ;
Jolliet, P ;
Bourin, M .
JOURNAL OF CHROMATOGRAPHY B, 2001, 758 (02) :129-135
[7]  
DECOCK KM, 2000, JAMA-J AM MED ASSOC, V283, P175
[8]  
FOWLER MG, 2002, 9 C RETR OPP INF SEA
[9]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial [J].
Guay, LA ;
Musoke, P ;
Fleming, T ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Ducar, C ;
Deseyve, M ;
Emel, L ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Dransfield, K ;
Bray, D ;
Mmiro, F ;
Jackson, JB .
LANCET, 1999, 354 (9181) :795-802
[10]  
McKenna SL, 1997, AIDS, V11, pS103